Skip to content

Metatrutide

Also called Retatrutide analog

Marketed as a triple GLP-1 / GIP / glucagon agonist in the retatrutide family.

  • TypePeptide
  • FormInjectable
  • Researched forMetabolic & Fat Loss

Where to get Metatrutide

Disguised Alpha
Injectable
Code CAMERON

21+ to enter. The only form sold. Research compound, not approved for human use.

Shop injectable at Disguised Alpha

The short version

  • Why people research itFat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
  • What the evidence isThis name is used in the research-chemical market for a GLP-1 / GIP / glucagon triple agonist, referring to the mechanism of Eli Lilly's retatrutide.
  • What to watchSevere belly pain that spreads to the back.

How Metatrutide works

Start with the search, because it is the finding. On 4 September 2026 a full-corpus search of NCBI PubTator3 for the string metatrutide returned count: 0.

So this section cannot be about what this molecule does, because no published experiment has ever been performed on it. It has to be about the mechanism the name points at, and about the specific things a name does not carry across.

The peptide sequence sold under this name is not published and does not correspond to a compound in clinical development.

  • Injectable

On the goal map: Appetite & satiety signaling (Lose fat)

Research on Metatrutide6 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Human clinical evidence

  • This name is used in the research-chemical market for a GLP-1 / GIP / glucagon triple agonist, referring to the mechanism of Eli Lilly's retatrutide. Retatrutide's phase 2 reported around 24% weight loss at 48 weeks — the largest figure any obesity drug has produced — and it is in phase 3.

  • What is sold under this name is not the trial drug. The clinical data belongs to a specific molecule made under pharmaceutical manufacturing.

Correlative data

  • Research-market use only. Reported experience mirrors the class — strong appetite suppression, GI effects, and a heart rate increase that shows up consistently and is the glucagon arm.

How the mechanism reads

  • Three receptors, three jobs: GLP-1 suppresses appetite and slows gastric emptying, GIP appears to improve tolerability and adipose insulin sensitivity, glucagon raises energy expenditure and drives hepatic fat oxidation.

    Mechanistic
  • Adding expenditure to intake suppression is why the ceiling moves. Every single- and dual-agonist works mostly by reducing what goes in; the glucagon arm is the first mechanism in the class that increases what goes out.

    Mechanistic
  • The predicted costs are equally mechanistic: higher heart rate, greater dependence on a correct receptor ratio, and — at 24% weight loss — real lean-mass loss without deliberate protein and resistance training.

    Mechanistic

Sources

  • Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. New England Journal of Medicine 2023 · PMID 37366315
  • Sanyal AJ, et al. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature Medicine 2024 · PMID 38858523
  • Bajaj HS, et al. Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial. Lancet 2026 · PMID 42250575
  • Harrison SA, et al. Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study. Journal of Hepatology 2024 · PMID 39002641
  • Guo W, et al. Discovery of ecnoglutide - a novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog. Molecular Metabolism 2023 · PMID 37364710
  • Yang Y, et al. Impact of a dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta-analysis. Diabetes, Obesity and Metabolism 2023 · PMID 37860884
  • He L, et al. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Internal Medicine 2022 · PMID 35344001
  • Stefanakis K, et al. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism 2024 · PMID 39481534
  • Sattar N, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes and Endocrinology 2021 · PMID 34425083
  • Muller TD, et al. Anti-obesity drug discovery: advances and challenges. Nature Reviews Drug Discovery 2022 · PMID 34815532

Metatrutide safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Personal or family history of medullary thyroid cancer or MEN2.
  • History of pancreatitis or gallstones.
  • Type 1 diabetes or insulin use, since an unverified glucose-lowering product is a hypoglycemia risk.
  • Pregnancy, trying to conceive, or under 18.
  • Any wish for a verified product: the sequence sold under this name is not published, so identity is unconfirmed.

What’s expected

  • If it truly acts as sold, GLP-1 style appetite loss and nausea.
  • Glucagon-driven rise in resting pulse, if the glucagon arm is real.
  • Possibly nothing at all, because the contents cannot be matched to a known molecule.

Watch for

  • Severe belly pain that spreads to the back.
  • Yellow eyes or right-sided pain.
  • Vomiting that persists.
  • Heart pounding at rest.

Labs that tell you it’s working

  • Lipase
  • HbA1c (Hemoglobin A1c)
  • Comprehensive Metabolic Panel (CMP)
  • Calcitonin (Thyrocalcitonin)

No published molecule matches this name; lines follow the claimed GLP-1, GIP and glucagon action, identity unverified.

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

A panel picked from how it works and what it can move: the tests, and why each is on it.

9 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order this panel

Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.

The Metabolic Health & Prediabetes panel, explained

Metatrutide FAQ4 common questions

Is Metatrutide approved for human use?
No. Metatrutide is a research compound.
What is Metatrutide researched for?
Fat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
Which labs show whether it's doing anything?
Lipase; HbA1c; Comprehensive Metabolic Panel; Calcitonin: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Metatrutide: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Metatrutide is. Skool covers how it is run.

Free on this page

What Metatrutide is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Metatrutide is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool